Dagaas, Blezy Faith .
HRN: 21-18-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2022
CO-AMOXICLAV 625MG (TAB)
09/02/2022
09/09/2022
ORAL
1 Cap
BID
Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes